Swiss Health Care | Switzerland Secrets To Longevity

Health

Groupe Mutuel Might Leave Santésuisse

Groupe Mutuel's CEO Thomas Boyer discusses the possibility of leaving Santésuisse, advocating for unity in health associations for the benefit of premium payers.

Helpany Expands to the USA: A New Chapter in Senior Care Innovation

Swiss startup Helpany sets its sights on the US, bringing its advanced AI-driven senior care solution to new markets in Spring 2024.

Zurich Research AI

Zurich Research AI: Detects Heart Defects

Zurich researchers develop AI to spot pulmonary hypertension in newborns, offering hope for early diagnosis and improved outcomes.

Sandoz Forecasts Growth and Increased Margins in 2024

Sandoz, now an independent entity, celebrates a year of growth, setting sights on heightened sales and margins for 2024.

Rotkreuz ZG Natural Gas Leak: 15 Residents Evacuated

In Rotkreuz ZG, a gas leak following a drilling mishap prompted a swift evacuation.

Digitalising Healthcare

Switzerland Will Spend CHF 400 Million on Digitalising Healthcare

Switzerland's National Council greenlights the CHF 400 million Digisanté program to advance healthcare digitalisation, amid calls for vigilant oversight.

Alcon

Alcon Targets $12 Billion Sales by 2027

Alcon aims for growth with a $12 billion revenue target by 2027, post-Novartis spin-off.

Swiss Health Care Sector Shortage: Spitex Launch Campaign

Switzerland faces a critical healthcare worker shortfall, with an urgent need for new entrants, spurring nationwide recruitment efforts.

Zambon Group

Zambon Group: Exclusive Licensing Deal for IPX203 in Europe

29 February 2024

Keystone/SDA - DARRON CUMMINGS Amneal Pharmaceuticals, aligning with Zambon Group, announces an exclusive licensing pact for IPX203 in key European regions.

Swiss biotech

Swiss Biotech Firm Idorsia: Stock Soars – but Why?

26 February 2024

Idorsia's Surging Stock: Speculations Amid Silence Keystone/SDA - GEORGIOS KEFALAS Swiss biotech firm Idorsia, based in Basel, has seen a spike in stock prices from just $2.

CSEM Join Forces With ClexBio to Fight Cardiovascular Issues

26 February 2024

CSEM teams up with Nordic innovator ClexBio to pioneer a bioreactor, a leap in lab-cultivated human veins for regenerative medicine.

Social Democrats Health Insurance Initiative Fails

24 February 2024

Swiss Center Rejects Health Premium Cap Proposal, Debates Cost and Solidarity in Healthcare Keystone/SDA - PETER SCHNEIDER The Center rejects the SP's premium relief initiative.

Alys Pharmaceuticals Launch with $100M from Medicxi

21 February 2024

Alys Pharmaceuticals, the immuno-dermatology trailblazer with a $100M boost from Medicxi.

Swissmedic

Swissmedic Approves New Drugs Against Cancer

12 February 2024

Swissmedic's latest approvals spotlight oncology with ten new cancer drugs leading the charge.

Swiss Breakthrough: Halting Ageing in Mice with Novel Drug

9 February 2024

Swiss researchers achieve a milestone in anti-ageing research by successfully slowing down the ageing process in mice, opening new avenues for human health advancements.

Public Warning: Pesticide Residues on Ceposa AG’s Dried Tomatoes

7 February 2024

Ceposa AG discovers harmful pesticide chlorpyrifos-ethyl in dried tomatoes, posing potential health risks.

Fribourg Cantonal Hospital Receives 175M CHF from the State

6 February 2024

The Fribourg Cantonal Hospital is set for a financial revival with a 175 million francs boost from the state, marking a significant step towards addressing its prolonged financial woes.

New Slimming Products Could Drive Costs up in the Healthcare Sector

5 February 2024

GLP-1 Drugs: A Costly Revolution in Obesity Treatment. Drugs with a punch like the new GLP-1 drugs inevitably lead to discussions about their cost.

Related Stories

Stay in Touch

Noteworthy

A production of UltraSwiss AG, 6340 Baar, Switzerland

Quick Links

Home Privacy GTC Contact Us About Us

Copyright © 2024 UltraSwiss AG 2024 All rights reserved